FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895888530> ?p ?o ?g. }

• W2895888530 endingPage "1016" @default.
• W2895888530 startingPage "1005" @default.
• W2895888530 abstract "The aim of this study was to develop and validate the novel microLC/MS-MRM method for the simultaneous quantification of six proteins: angiopoietin 2 (Angpt-2), soluble form of fms-like tyrosine kinase 1 (sFLT-1), plasminogen activator inhibitor 1 (PAI-1), tissue plasminogen activator (t-PA), endocan (ESM-1), soluble form of E-selectin (sE-sel), and one peptide: adrenomedullin (ADM) in mouse plasma. Two approaches were compared: a stable isotope dilution (SID) method- used as a reference and a modified SID (mSID) procedure. In SID strategy the calibration curves were used, whereas in mSID the ratio between the chromatogram peak area of endogenous tryptic peptides at unknown concentration to chromatogram peak area of exogenous, stable isotope-labelled internal standards (SISs) added to the sample at known concentration was calculated. The microLC/MS-MRM method in the SID approach was linear from 0.250 pmol/mL to 250 pmol/mL for Angpt-2; 5 pmol/mL to 5000 pmol/mL for sFLT-1; 2.5 pmol/mL to 5000 pmol/mL for PAI-1; 0.375 pmol/mL to 250 pmol/mL for t-PA; 0.375 pmol/mL to 187.5 pmol/mL for ESM-1; 2.5 pmol/mL to 5000 pmol/mL for sE-sel and 0.375 pmol/mL to 250 pmol/mL for ADM. LPS-induced changes in plasma assessed based on SID and mSID approaches gave comparable quantitative results and featured LPS-induced dysregulation of endothelial permeability (Angpt-2, sFLT-1), glycocalyx injury (SDC-1) accompanied by a pro-thrombotic response (PAI-1). In addition, we applied microLC/MS-MRM method with mSID strategy to analyze human plasma samples from patients with chronic myeloid leukemia (CML) and obstructive sleep apnoea (OSA) and demonstrated usefulness of the method to characterize endothelial function in humans. In conclusion, the microLC/MS-MRM method with mSID strategy applied for simultaneous quantification of protein biomarkers of endothelial function in plasma represents a novel targeted proteomic platform for the comprehensive evaluation of endothelial function in mice and humans." @default.
• W2895888530 created "2018-10-26" @default.
• W2895888530 creator A5009688129 @default.
• W2895888530 creator A5015641664 @default.
• W2895888530 creator A5020305146 @default.
• W2895888530 creator A5029712912 @default.
• W2895888530 creator A5040956552 @default.
• W2895888530 creator A5040987022 @default.
• W2895888530 creator A5045778168 @default.
• W2895888530 creator A5046267916 @default.
• W2895888530 creator A5065651170 @default.
• W2895888530 creator A5083453459 @default.
• W2895888530 date "2019-03-01" @default.
• W2895888530 modified "2023-09-23" @default.
• W2895888530 title "Quantitative measurement of selected protein biomarkers of endothelial dysfunction in plasma by micro-liquid chromatography-tandem mass spectrometry based on stable isotope dilution method" @default.
• W2895888530 cites W1964062551 @default.
• W2895888530 cites W1968514964 @default.
• W2895888530 cites W1974500649 @default.
• W2895888530 cites W1975152371 @default.
• W2895888530 cites W1975669637 @default.
• W2895888530 cites W1981946236 @default.
• W2895888530 cites W1982783885 @default.
• W2895888530 cites W1983307337 @default.
• W2895888530 cites W1988867540 @default.
• W2895888530 cites W1991615383 @default.
• W2895888530 cites W1991683095 @default.
• W2895888530 cites W1995151961 @default.
• W2895888530 cites W2014960549 @default.
• W2895888530 cites W2029828957 @default.
• W2895888530 cites W2043454263 @default.
• W2895888530 cites W2068481474 @default.
• W2895888530 cites W2111077493 @default.
• W2895888530 cites W2113766156 @default.
• W2895888530 cites W2119115625 @default.
• W2895888530 cites W2119790812 @default.
• W2895888530 cites W2123095004 @default.
• W2895888530 cites W2123422742 @default.
• W2895888530 cites W2141868068 @default.
• W2895888530 cites W2145343991 @default.
• W2895888530 cites W2154670730 @default.
• W2895888530 cites W2157225099 @default.
• W2895888530 cites W2160465469 @default.
• W2895888530 cites W2167741910 @default.
• W2895888530 cites W2170791918 @default.
• W2895888530 cites W2255691977 @default.
• W2895888530 cites W2289813931 @default.
• W2895888530 cites W2294883346 @default.
• W2895888530 cites W2312472983 @default.
• W2895888530 cites W2330679995 @default.
• W2895888530 cites W2543115777 @default.
• W2895888530 cites W2575911653 @default.
• W2895888530 cites W2595826765 @default.
• W2895888530 cites W2610130212 @default.
• W2895888530 cites W2610421378 @default.
• W2895888530 cites W2611695796 @default.
• W2895888530 cites W2735817878 @default.
• W2895888530 cites W2739857744 @default.
• W2895888530 cites W2768631628 @default.
• W2895888530 cites W2789846220 @default.
• W2895888530 cites W2796760647 @default.
• W2895888530 cites W744255471 @default.
• W2895888530 doi "https://doi.org/10.1016/j.talanta.2018.10.067" @default.
• W2895888530 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30609507" @default.
• W2895888530 hasPublicationYear "2019" @default.
• W2895888530 type Work @default.
• W2895888530 sameAs 2895888530 @default.
• W2895888530 citedByCount "12" @default.
• W2895888530 countsByYear W28958885302019 @default.
• W2895888530 countsByYear W28958885302020 @default.
• W2895888530 countsByYear W28958885302021 @default.
• W2895888530 countsByYear W28958885302022 @default.
• W2895888530 countsByYear W28958885302023 @default.
• W2895888530 crossrefType "journal-article" @default.
• W2895888530 hasAuthorship W2895888530A5009688129 @default.
• W2895888530 hasAuthorship W2895888530A5015641664 @default.
• W2895888530 hasAuthorship W2895888530A5020305146 @default.
• W2895888530 hasAuthorship W2895888530A5029712912 @default.
• W2895888530 hasAuthorship W2895888530A5040956552 @default.
• W2895888530 hasAuthorship W2895888530A5040987022 @default.
• W2895888530 hasAuthorship W2895888530A5045778168 @default.
• W2895888530 hasAuthorship W2895888530A5046267916 @default.
• W2895888530 hasAuthorship W2895888530A5065651170 @default.
• W2895888530 hasAuthorship W2895888530A5083453459 @default.
• W2895888530 hasConcept C10390740 @default.
• W2895888530 hasConcept C162356407 @default.
• W2895888530 hasConcept C171679685 @default.
• W2895888530 hasConcept C185592680 @default.
• W2895888530 hasConcept C2777152744 @default.
• W2895888530 hasConcept C2779281246 @default.
• W2895888530 hasConcept C31827203 @default.
• W2895888530 hasConcept C43617362 @default.
• W2895888530 hasConcept C55493867 @default.
• W2895888530 hasConcept C71043704 @default.
• W2895888530 hasConceptScore W2895888530C10390740 @default.
• W2895888530 hasConceptScore W2895888530C162356407 @default.
• W2895888530 hasConceptScore W2895888530C171679685 @default.
• W2895888530 hasConceptScore W2895888530C185592680 @default.
• W2895888530 hasConceptScore W2895888530C2777152744 @default.

• next